Compare Sign (SIGN) vs Symbiosis (SIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sign vs Symbiosis — how do they compare? Sign trades at Rp113.13 (market cap Rp269,12M, Rp72,01M 24h volume), while Symbiosis trades at Rp293.08 (market cap Rp34,08M, Rp2,71M 24h volume). The key difference: Sign is far larger — about 7.9× Symbiosis's market cap, and Sign's circulating supply is 2,4B / 10B SIGN (24%) versus 97M / 99,5M SIS (98%) for Symbiosis. Which is the better fit depends on your goals — on Pluang, investors hold Sign for 21 Days and Symbiosis for 13 Days on average.
| SIGN | SIS | |
|---|---|---|
Market Cap | Rp269,12M | Rp34,08M |
Volume (24h) | Rp72,01M | Rp2,71M |
Circulating Supply | 2,4B / 10B SIGN (24%) | 97M / 99,5M SIS (98%) |
Typical Hold Time | 21 Days | 13 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SIGN token currently trades at Rp115.74 with a market cap of Rp275.68M, showing bearish technical signals with 18 sell indicators versus 3 buy signals. The token faces resistance at Rp117-Rp120 while finding support at Rp112-Rp115 levels. With only 24% of the maximum 10M supply in circulation and average hold time of 21 days, the asset shows limited distribution but stable holding patterns among current investors.
Overall outlook remains cautious due to strong bearish technical momentum despite neutral oscillators. Key opportunity lies in potential rebound from oversold RSI levels, while major risks include low liquidity and limited market depth. Investors should monitor breakout above Rp120 resistance for trend reversal confirmation.
Symbiosis (SIS) shows limited market activity with a modest market cap of Rp34.08M and high circulating supply utilization at 98%. The token exhibits a short average hold time of 13 days, suggesting active trading but potentially weak long-term holder confidence. No recent protocol updates or significant ecosystem developments have been recorded, indicating stagnant project momentum.
Overall outlook remains cautious due to low market cap and limited fundamental catalysts. Key opportunities include potential ecosystem growth if development resumes, while major risks involve low liquidity, high volatility typical of small-cap tokens, and regulatory uncertainty in the crypto space.
About Sign
Sign is developing global infrastructure for credential verification and token distribution through two main products. The Sign Protocol is an omni-chain attestation protocol that supports digital public infrastructure for governments and serves as a foundational layer for decentralized applications. TokenTable is a smart contract-based platform that streamlines token distribution processes such as airdrops, vesting, and unlocks, allowing for seamless and transparent on-chain management.
Read more on SIGN →About Symbiosis
Symbiosis is a platform for cross-chain swaps that eliminates the need for multiple transactions. It aggregates liquidity from various Automated Market Makers (AMMs) and Decentralized Exchanges (DEXs) across EVM and non-EVM chains. The platform uses a decentralized Relayers Network, consisting of relayer nodes that verify and transfer information across blockchains. This network ensures secure data transfer and enhances security against central points of failure. Relayer nodes must stake SIS tokens to participate in the consensus and process swaps.
Read more on SIS →
